DALLAS, March, 24, 2014 /PRNewswire/ -- Securities lawyers at Deans & Lyons announce an investigation of the board of Star Scientific Inc. (NasdaqGM: STSI). Concerned investors are encouraged to contact securities attorney Hamilton Lindley by clicking here.

"In a Consumer Update issued on December 31, 2013 the FDA warned consumers to avoid using dietary supplements such as and including Anatabloc to cure concussions and other traumatic brain injuries," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed to the Star Scientific Inc. shareholders and consumers."

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. STSI stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033 with questions or concerns.

Hamilton Lindley
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
Phone: 214-736-7861
Fax: 214-965-8505
Toll-free: 877-819-8033
hlindley@deanslyons.com
www.deanslyons.com

SOURCE Deans & Lyons LLP

Copyright 2014 PR Newswire

Rock Creek Pharmaceuticals (CE) (USOTC:RCPIQ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Rock Creek Pharmaceuticals (CE) Charts.
Rock Creek Pharmaceuticals (CE) (USOTC:RCPIQ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Rock Creek Pharmaceuticals (CE) Charts.